22 July 2019 (Mexico City, Mexico) – New evidence presented at the 10th IAS Conference on HIV Science (IAS 2019) offers further analysis from the highly-publicized Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which just a few weeks ago finally put to rest the long-standing concern that certain hormonal contraceptives might increase women’s risk of becoming infected with HIV.
ECHO was a randomized, open-label clinical trial conducted in four African countries that compared HIV risk among women on the three most commonly used methods of hormonal contraception: the DMPA-IM shot, a copper intrauterine device (IUD) and a levonorgestrel (LNG) implant.
Continue reading